The possibilities of monitoring the effectiveness of anticoagulant therapy using a thrombodynamics test in patients with left atrial appendage thrombosis with non-valvular atrial fibrillation: clinical cases
Open Access
- 13 June 2025
- journal article
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 32 (2) , 1-7
Abstract
Clinical observations of the possibility of using the thrombodynamics test (TD) in comparison with standard hemostasis tests in patients with non-valvular atrial fibrillation (AF) and detected thrombosis of the left atrial appendage against the background constant oral anticoagulants are presented. It has been shown that the transfer from one direct oral anticoagulant (DOACs) to another (with a different mechanism of action), as well as from DOACs to warfarin, can change the state of the blood plasma coagulation system towards both hyper- and hypocoagulation. Unlike standard hemostasis tests, TD can be used to assess the prothrombotic status of a patient with AF and personalized selection of effective anticoagulant therapy.Keywords
This publication has 16 references indexed in Scilit:
- New prospects for assessing the hemostasis system in atrial fibrillation and left atrial appendage thrombosisAtherothrombosis, 2023
- Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral AnticoagulantsRational Pharmacotherapy in Cardiology, 2022
- 2020 Clinical guidelines for Atrial fibrillation and atrial flutterRussian Journal of Cardiology, 2021
- Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillationEP Europace, 2021
- Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxabanAtherothrombosis, 2020
- Laboratory aspects of hemostasis in neonatesPediatric Hematology/Oncology and Immunopathology, 2019
- Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH CalibratorAnnals of Pharmacotherapy, 2018
- Thrombodynamics—A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatmentPLOS ONE, 2018
- Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial FibrillationCanadian Journal of Cardiology, 2018
- Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulantsVascular Health and Risk Management, 2017